OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 90 filers reported holding OLEMA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,699,679 | +31.5% | 2,242,889 | -3.9% | 0.00% | 0.0% |
| Q2 2023 | $21,069,699 | +509.5% | 2,333,300 | +134.2% | 0.00% | – |
| Q1 2023 | $3,456,734 | +35.2% | 996,177 | -4.5% | 0.00% | – |
| Q4 2022 | $2,555,827 | -28.9% | 1,043,195 | -19.9% | 0.00% | – |
| Q3 2022 | $3,593,000 | -32.4% | 1,301,926 | -0.3% | 0.00% | – |
| Q2 2022 | $5,313,000 | -51.1% | 1,305,504 | -48.9% | 0.00% | – |
| Q1 2022 | $10,874,000 | -49.5% | 2,552,949 | +11.1% | 0.00% | -100.0% |
| Q4 2021 | $21,512,000 | -66.6% | 2,298,164 | -1.8% | 0.00% | -50.0% |
| Q3 2021 | $64,490,000 | +56.9% | 2,339,975 | +59.3% | 0.00% | +100.0% |
| Q2 2021 | $41,108,000 | -14.7% | 1,469,179 | +1.1% | 0.00% | 0.0% |
| Q1 2021 | $48,211,000 | +46.4% | 1,453,020 | +112.2% | 0.00% | 0.0% |
| Q4 2020 | $32,921,000 | – | 684,709 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 7,803,600 | $96,374,460 | 6.54% |
| Logos Global Management LP | 3,743,875 | $46,236,856 | 6.17% |
| MPM BioImpact LLC | 1,857,681 | $22,942,360 | 6.12% |
| Cormorant Asset Management, LP | 4,504,764 | $55,633,835 | 3.24% |
| BVF INC/IL | 9,135,893 | $112,828,279 | 3.04% |
| Vivo Capital, LLC | 1,873,704 | $23,140,244 | 2.54% |
| Altium Capital Management LP | 335,000 | $4,137,250 | 2.16% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 407,801 | $5,036,342 | 1.53% |
| HighVista Strategies LLC | 247,880 | $3,061,318 | 1.42% |
| ACUTA CAPITAL PARTNERS, LLC | 153,007 | $1,889,636 | 1.27% |